A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex.
Jodi Y SoShivali FulchandChristine Y WongShufeng LiJaron NazaroffEmily S GorellMark P de SouzaDedee F MurrellJoyce M TengAlbert S ChiouJean Y TangPublished in: Orphanet journal of rare diseases (2022)
In the largest international cross-sectional survey of EBS patients conducted, respondents reported extensive disease burden including significant wounding, pain, itch, difficulty walking, and impact on QOL. Age stratified disease manifestations. These findings suggest significant unmet need, and treatment and counseling for EBS patients should consider age-specific differences.